Patients who are at low risk of metastatic disease, defined by criteria based on prostate-specific antigen (PSA) and Gleason score, do not need a bone scan for staging. Bone scans may be useful if there are findings in the patient's history or physical examination, which raise the suspicion of bony involvement.

Conditions: Prostate Cancer

Diagnostic Tests: Nuclear Bone Scan

Sources

• Abuzallouf S, Dayes I, Lukka H. Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J Urol. 2004 Jun;171(6 Pt 1):2122-7. (PubMed)
• American Urological Association. Five Things Physicians and Patients Should Question. 2013 Feb [cited 2015 Mar 16]. (ChoosingWisely)
• Eberhardt SC, Carter S, Casalino DD, Merrick G, Frank SJ, Gottschalk AR, et al. ACR Appropriateness Criteria prostate cancer--pretreatment detection, staging, and surveillance. J Am Coll Radiol. 2013 Feb;10(2):83-92. (PubMed)
• Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014 Jan;65(1):124-37. (PubMed)
• Kim L, Min M, Roos D, Nguyen L, Yeoh E. Are staging investigations being overused in patients with low and intermediate risk prostate cancer? J Med Imaging Radiat Oncol. 2015 Feb;59(1):77-81. (PubMed)
• Makarov DV, Desai RA, Yu JB, Sharma R, Abraham N, Albertsen PC, et al. The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population. J Urol. 2012 Jan;187(1):97-102. (PubMed)
• Wollin DA, Makarov DV. Guideline of Guidelines: Prostate Cancer Imaging. BJU Int. 2015 Feb 26. (PubMed)